Viewing Study NCT00003356


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-03-18 @ 8:18 AM
Study NCT ID: NCT00003356
Status: COMPLETED
Last Update Posted: 2013-10-16
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma
Sponsor: University of Rochester
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module